Skrzypiec-Spring, M.; Urbaniak, J.; Sapa-Wojciechowska, A.; Pietkiewicz, J.; Orda, A.; Karolko, B.; Danielewicz, R.; Bil-Lula, I.; Woźniak, M.; Schulz, R.;
et al. Matrix Metalloproteinase-2 Inhibition in Acute Ischemia-Reperfusion Heart Injury—Cardioprotective Properties of Carvedilol. Pharmaceuticals 2021, 14, 1276.
https://doi.org/10.3390/ph14121276
AMA Style
Skrzypiec-Spring M, Urbaniak J, Sapa-Wojciechowska A, Pietkiewicz J, Orda A, Karolko B, Danielewicz R, Bil-Lula I, Woźniak M, Schulz R,
et al. Matrix Metalloproteinase-2 Inhibition in Acute Ischemia-Reperfusion Heart Injury—Cardioprotective Properties of Carvedilol. Pharmaceuticals. 2021; 14(12):1276.
https://doi.org/10.3390/ph14121276
Chicago/Turabian Style
Skrzypiec-Spring, Monika, Joanna Urbaniak, Agnieszka Sapa-Wojciechowska, Jadwiga Pietkiewicz, Alina Orda, Bożena Karolko, Regina Danielewicz, Iwona Bil-Lula, Mieczysław Woźniak, Richard Schulz,
and et al. 2021. "Matrix Metalloproteinase-2 Inhibition in Acute Ischemia-Reperfusion Heart Injury—Cardioprotective Properties of Carvedilol" Pharmaceuticals 14, no. 12: 1276.
https://doi.org/10.3390/ph14121276
APA Style
Skrzypiec-Spring, M., Urbaniak, J., Sapa-Wojciechowska, A., Pietkiewicz, J., Orda, A., Karolko, B., Danielewicz, R., Bil-Lula, I., Woźniak, M., Schulz, R., & Szeląg, A.
(2021). Matrix Metalloproteinase-2 Inhibition in Acute Ischemia-Reperfusion Heart Injury—Cardioprotective Properties of Carvedilol. Pharmaceuticals, 14(12), 1276.
https://doi.org/10.3390/ph14121276